Global Leukocyte Surface Antigen CD47 Market Status and Outlook 2018-2025

August 2018 | 138 pages | ID: G5A7021D934EN
99Strategy

Abstracts

REPORT SNAPSHOT

Key Content of Chapters (Including and can be customized, report is a semifinished version, and it takes 48-72 hours to upgrade)

Part 1:
Terminology Definition, Industry Chain,Industry Dynamics & Regulations and Global Market Overview
Part 2:
Upstream (Raw Materials/Components) & Manufacturing (Procurement Methods & Channels and Cost), Major Regional Production Overview and Trade Flow
Part 3:
Product Segment Overview and Market Status
Part 4:
Application/End-User Segment Overview and Market Status
Part 5:
Region Segment Overview and Market Status
Part 6:
Product & Application Segment Production & Demand by Region
Part 7:
Market Forecast by Product, Application & Region
Part 8:
Company information, Products & Services and Business Operation (Sales, Cost, Margin etc.)
Part 9:
Market Competition and Environment for New Entrants
Part 10:
Conclusion

Market Segment as follows:

Key Companies

• Aurigene Discovery Technologies Ltd
• Celgene Corp
• Forty Seven Inc
• Surface Oncology Inc
• Trillium Therapeutics Inc

Market by Type

• B-6H12
• ALX-148
• CC-90002
• PSTx-23
• Others

Market by Application

• Lymphoma
• Ovarian Cancer
• Ischemia Reperfusion Injury
• Kindney Transplant Rejection
• Others

Contents

PART 1 INDUSTRY OVERVIEW (200 USD)

1.1 Leukocyte Surface Antigen CD47 Industry
  1.1.1 Market Development
  1.1.2 Terminology Definition in the Report
    1.1.2.1 Production
    1.1.2.2 Demand
    1.1.2.3 Sales Revenue
    1.1.2.4 Ex-factory Price & Sales Price
    1.1.2.5 Cost
    1.1.2.6 Gross Margin
1.2 Products & Services Scope
1.3 Industry Chain
1.4 Industry Dynamics & Regulations
1.5 Global Market Overview

PART 2 UPSTREAM & PRODUCTION (200 USD)

2.1 Raw Materials / Components
2.2 Procurement Methods & Channels
2.3 Cost Structure & Manufacturing
2.4 Industry Capacity
2.5 Production Distribution by Geography
  2.5.1 Production in Major Regions / Countries
  2.5.2 Trade Flow Overview

PART 3 PRODUCT SEGMENT (400 USD)

3.1 Introduction by Type
  3.1.1 B-6H12
  3.1.2 ALX-148
  3.1.3 CC-90002
  3.1.4 PSTx-23
  3.1.5 Others
3.2 Market Status

PART 4 APPLICATION / END-USER SEGMENT (400 USD)

4.1 Introduction by Application
  4.1.1 Lymphoma
  4.1.2 Ovarian Cancer
  4.1.3 Ischemia Reperfusion Injury
  4.1.4 Kindney Transplant Rejection
  4.1.5 Others
4.2 Market Status

PART 5 REGIONAL MARKET (600 USD)

5.1 Market Overview
5.2 by Region
  5.2.1 North America
    5.2.1.1 United States Market Size and Growth (2015-2018E)
    5.2.1.2 Canada Market Size and Growth (2015-2018E)
    5.2.1.3 Mexico Market Size and Growth (2015-2018E)
  5.2.2 Europe
    5.2.2.1 Germany Market Size and Growth (2015-2018E)
    5.2.2.2 UK Market Size and Growth (2015-2018E)
    5.2.2.3 France Market Size and Growth (2015-2018E)
    5.2.2.4 Italy Market Size and Growth (2015-2018E)
    5.2.2.5 Spain Market Size and Growth (2015-2018E)
    5.2.2.6 Netherlands Market Size and Growth (2015-2018E)
    5.2.2.7 Poland Market Size and Growth (2015-2018E)
    5.2.2.8 Belgium Market Size and Growth (2015-2018E)
    5.2.2.9 Sweden Market Size and Growth (2015-2018E)
    5.2.2.10 Austria Market Size and Growth (2015-2018E)
    5.2.2.11 Denmark Market Size and Growth (2015-2018E)
    5.2.2.12 Switzerland Market Size and Growth (2015-2018E)
    5.2.2.13 Russia Market Size and Growth (2015-2018E)
  5.2.3 Asia-Pacific
    5.2.3.1 China Market Size and Growth (2015-2018E)
    5.2.3.2 India Market Size and Growth (2015-2018E)
    5.2.3.3 Japan Market Size and Growth (2015-2018E)
    5.2.3.4 Korea Market Size and Growth (2015-2018E)
    5.2.3.5 Australia Market Size and Growth (2015-2018E)
    5.2.3.6 Indonesia Market Size and Growth (2015-2018E)
    5.2.3.7 Thailand Market Size and Growth (2015-2018E)
    5.2.3.8 Malaysia Market Size and Growth (2015-2018E)
    5.2.3.9 Singapore Market Size and Growth (2015-2018E)
    5.2.3.10 Philippines Market Size and Growth (2015-2018E)
  5.2.4 South America
    5.2.4.1 Brazil Market Size and Growth (2015-2018E)
    5.2.4.2 Argentina Market Size and Growth (2015-2018E)
    5.2.4.3 Columbia Market Size and Growth (2015-2018E)
    5.2.4.4 Chile Market Size and Growth (2015-2018E)
    5.2.4.5 Peru Market Size and Growth (2015-2018E)
    5.2.4.6 Puerto Rico Market Size and Growth (2015-2018E)
    5.2.4.7 Ecuador Market Size and Growth (2015-2018E)
  5.2.5 Middle East
    5.2.5.1 Saudi Arabia Market Size and Growth (2015-2018E)
    5.2.5.2 Iran Market Size and Growth (2015-2018E)
    5.2.5.3 UAE Market Size and Growth (2015-2018E)
    5.2.5.4 Oman Market Size and Growth (2015-2018E)
    5.2.5.5 Kuwait Market Size and Growth (2015-2018E)
    5.2.5.6 Iraq Market Size and Growth (2015-2018E)
    5.2.5.7 Turkey Market Size and Growth (2015-2018E)
  5.2.6 Africa
    5.2.6.1 South Africa Market Size and Growth (2015-2018E)
    5.2.6.2 Egypt Market Size and Growth (2015-2018E)
    5.2.6.3 Nigeria Market Size and Growth (2015-2018E)
    5.2.6.4 Algeria Market Size and Growth (2015-2018E)
    5.2.6.5 Angola Market Size and Growth (2015-2018E)
    5.2.6.6 Morocco Market Size and Growth (2015-2018E)
    5.2.6.7 Sudan Market Size and Growth (2015-2018E)

PART 6 MARKET SUBDIVISION (800 USD)

6.1 Regional Production
  6.1.1 Production by Type
    6.1.1.1 B-6H12 Production by Region
    6.1.1.2 ALX-148 Production by Region
    6.1.1.3 CC-90002 Production by Region
    6.1.1.4 PSTx-23 Production by Region
    6.1.1.5 Others Production by Region
  6.1.2 Production by Application
    6.1.2.1 Lymphoma Production by Region
    6.1.2.2 Ovarian Cancer Production by Region
    6.1.2.3 Ischemia Reperfusion Injury Production by Region
    6.1.2.4 Kindney Transplant Rejection Production by Region
    6.1.2.5 Others Production by Region
6.2 Regional Demand
  6.2.1 Demand by Type
    6.2.1.1 B-6H12 Demand by Region
    6.2.1.2 ALX-148 Demand by Region
    6.2.1.3 CC-90002 Demand by Region
    6.2.1.4 PSTx-23 Demand by Region
    6.2.1.5 Others Demand by Region
  6.2.2 Demand by Application
    6.2.2.1 Lymphoma Demand by Region
    6.2.2.2 Ovarian Cancer Demand by Region
    6.2.2.3 Ischemia Reperfusion Injury Demand by Region
    6.2.2.4 Kindney Transplant Rejection Demand by Region
    6.2.2.5 Others Demand by Region

PART 7 MARKET FORECAST (200 USD)

7.1 Global Forecast
7.2 Forecast by Type
7.3 Forecast by Application
7.4 Forecast by Region

PART 8 KEY COMPANIES LIST (600 USD)

8.1 Aurigene Discovery Technologies Ltd
  8.1.2 Company Information
  8.1.2 Products & Services
  8.1.3 Business Operation
8.2 Celgene Corp
  8.2.1 Company Information
  8.2.2 Products & Services
  8.2.3 Business Operation
8.3 Forty Seven Inc
  8.3.1 Company Information
  8.3.2 Products & Services
  8.3.3 Business Operation
8.4 Surface Oncology Inc
  8.4.1 Company Information
  8.4.2 Products & Services
  8.4.3 Business Operation
8.5 Trillium Therapeutics Inc
  8.5.1 Company Information
  8.5.2 Products & Services
  8.5.3 Business Operation

PART 9 COMPANY COMPETITION (500 USD)

9.1 Market by Company
9.2 Price & Gross Margin
9.3 Competitive Environment for New Entrants
  9.3.1 Michael Porter's Five Forces Model
  9.3.2 SWOT

PART 10 RESEARCH CONCLUSION (100 USD)

List Of Tables

LIST OF TABLES

Table Leukocyte Surface Antigen CD47 Industry Dynamics & Regulations List
Table Global Leukocyte Surface Antigen CD47 Sales Revenue, Cost and Margin, 2015-2018E
Table Global Leukocyte Surface Antigen CD47 Market Status by Type 2015-2018E, in USD Million
Table Global Leukocyte Surface Antigen CD47 Market Status by Application 2015-2018E, in USD Million
Table Global Leukocyte Surface Antigen CD47 Market Status by Application 2015-2018E, in Volume
Table Global Leukocyte Surface Antigen CD47 Market by Region 2015-2018E, in USD Million
Table Global Leukocyte Surface Antigen CD47 Market Share by Region in 2018, in USD Million
Table Global Leukocyte Surface Antigen CD47 Market by Region 2015-2018E, in Volume
Table Global Leukocyte Surface Antigen CD47 Market Share by Region in 2018, in Volume
Table B-6H12 Production Value by Region 2015-2018E, in USD Million
Table B-6H12 Production Volume by Region 2015-2018E, in Volume
Table ALX-148 Production Value by Region 2015-2018E, in USD Million
Table ALX-148 Production Volume by Region 2015-2018E, in Volume
Table CC-90002 Production Value by Region 2015-2018E, in USD Million
Table CC-90002 Production Volume by Region 2015-2018E, in Volume
Table PSTx-23 Production Value by Region 2015-2018E, in USD Million
Table PSTx-23 Production Volume by Region 2015-2018E, in Volume
Table Others Production Value by Region 2015-2018E, in USD Million
Table Others Production Volume by Region 2015-2018E, in Volume
Table Lymphoma Production Value by Region 2015-2018E, in USD Million
Table Lymphoma Production Volume by Region 2015-2018E, in Volume
Table Ovarian Cancer Production Value by Region 2015-2018E, in USD Million
Table Ovarian Cancer Production Volume by Region 2015-2018E, in Volume
Table Ischemia Reperfusion Injury Production Value by Region 2015-2018E, in USD Million
Table Ischemia Reperfusion Injury Production Volume by Region 2015-2018E, in Volume
Table Kindney Transplant Rejection Production Value by Region 2015-2018E, in USD Million
Table Kindney Transplant Rejection Production Volume by Region 2015-2018E, in Volume
Table Others Production Value by Region 2015-2018E, in USD Million
Table Others Production Volume by Region 2015-2018E, in Volume
Table B-6H12 Market Size by Region 2015-2018E, in USD Million
Table B-6H12 Market Size by Region 2015-2018E, in Volume
Table ALX-148 Market Size by Region 2015-2018E, in USD Million
Table ALX-148 Market Size by Region 2015-2018E, in Volume
Table CC-90002 Market Size by Region 2015-2018E, in USD Million
Table CC-90002 Market Size by Region 2015-2018E, in Volume
Table PSTx-23 Market Size by Region 2015-2018E, in USD Million
Table PSTx-23 Market Size by Region 2015-2018E, in Volume
Table Others Market Size by Region 2015-2018E, in USD Million
Table Others Market Size by Region 2015-2018E, in Volume
Table Lymphoma Market Size by Region 2015-2018E, in USD Million
Table Lymphoma Market Size by Region 2015-2018E, in Volume
Table Ovarian Cancer Market Size by Region 2015-2018E, in USD Million
Table Ovarian Cancer Market Size by Region 2015-2018E, in Volume
Table Ischemia Reperfusion Injury Market Size by Region 2015-2018E, in USD Million
Table Ischemia Reperfusion Injury Market Size by Region 2015-2018E, in Volume
Table Kindney Transplant Rejection Market Size by Region 2015-2018E, in USD Million
Table Kindney Transplant Rejection Market Size by Region 2015-2018E, in Volume
Table Others Market Size by Region 2015-2018E, in USD Million
Table Others Market Size by Region 2015-2018E, in Volume
Table GlobalLeukocyte Surface Antigen CD47 Forecast by Type 2019F-2025F, in USD Million
Table Leukocyte Surface Antigen CD47 Forecast by Type 2019F-2025F, in Volume
Table Leukocyte Surface Antigen CD47 Market Forecast by Application / End-User 2019F-2025F, in USD Million
Table Leukocyte Surface Antigen CD47 Market Forecast by Application / End-User 2019F-2025F, in Volume
Table Leukocyte Surface Antigen CD47 Market Forecast by Region 2019F-2025F, in USD Million
Table Leukocyte Surface Antigen CD47 Market Forecast by Region 2019F-2025F, in Volume
Table Aurigene Discovery Technologies Ltd Information
Table Leukocyte Surface Antigen CD47 Sales, Cost, Margin of Aurigene Discovery Technologies Ltd
Table Celgene Corp Information
Table Leukocyte Surface Antigen CD47 Sales, Cost, Margin of Celgene Corp
Table Forty Seven Inc Information
Table Leukocyte Surface Antigen CD47 Sales, Cost, Margin of Forty Seven Inc
Table Surface Oncology Inc Information
Table Leukocyte Surface Antigen CD47 Sales, Cost, Margin of Surface Oncology Inc
Table Trillium Therapeutics Inc Information
Table Leukocyte Surface Antigen CD47 Sales, Cost, Margin of Trillium Therapeutics Inc
Table Global Leukocyte Surface Antigen CD47 Sales Revenue by Company 2015-2017, in USD Million
Table Global Leukocyte Surface Antigen CD47 Sales Volume by Company 2015-2017, in Volume
Table Global Leukocyte Surface Antigen CD47 Sales Volume by Company in 2018, in Volume

List Of Figures

LIST OF FIGURES

Figure Leukocyte Surface Antigen CD47 Picture
Figure Leukocyte Surface Antigen CD47 Industry Chain Diagram
Figure Global Leukocyte Surface Antigen CD47 Sales Revenue 2015-2018E, in USD Million
Figure Global Leukocyte Surface Antigen CD47 Sales Volume 2015-2018E, in Volume
Figure Global Leukocyte Surface Antigen CD47 Market Status by Type 2015-2018E, in Volume
Figure North America Leukocyte Surface Antigen CD47 Market Size and Growth 2015-2018E, in USD Million
Figure North America Leukocyte Surface Antigen CD47 Market Size and Growth 2015-2018E, in Volume
Figure Europe Leukocyte Surface Antigen CD47 Market Size and Growth 2015-2018E, in USD Million
Figure Europe Leukocyte Surface Antigen CD47 Market Size and Growth 2015-2018E, in Volume
Figure Asia-Pacific Leukocyte Surface Antigen CD47 Market Size and Growth 2015-2018E, in USD Million
Figure Asia-Pacific Leukocyte Surface Antigen CD47 Market Size and Growth 2015-2018E, in Volume
Figure South America Leukocyte Surface Antigen CD47 Market Size and Growth 2015-2018E, in USD Million
Figure South America Leukocyte Surface Antigen CD47 Market Size and Growth 2015-2018E, in Volume
Figure Middle East Leukocyte Surface Antigen CD47 Market Size and Growth 2015-2018E, in USD Million
Figure Middle East Leukocyte Surface Antigen CD47 Market Size and Growth 2015-2018E, in Volume
Figure Africa Leukocyte Surface Antigen CD47 Market Size and Growth 2015-2018E, in USD Million
Figure Africa Leukocyte Surface Antigen CD47 Market Size and Growth 2015-2018E, in Volume
Figure Global Leukocyte Surface Antigen CD47 Sales Revenue Forecast 2019F-2025F, in USD Million
Figure Global Leukocyte Surface Antigen CD47 Sales Volume Forecast 2019F-2025F, in Volume
Figure Global Leukocyte Surface Antigen CD47 Sales Price Forecast 2019F-2025F
Figure Global Leukocyte Surface Antigen CD47 Gross Margin Forecast 2019F-2025F
Figure Global Leukocyte Surface Antigen CD47 Sales Revenue by Company in 2018, in USD Million
Figure Global Leukocyte Surface Antigen CD47 Price by Company in 2018
Figure Global Leukocyte Surface Antigen CD47 Gross Margin by Company in 2018